Yüklüyor......

Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma

PURPOSE: Minimal residual disease (MRD) presents a significant hurdle to curing metastatic neuroblastoma (NB). Biologic therapies directed against MRD can improve outcome. Evaluating treatment efficacy requires MRD measurement, which serves as surrogate endpoint. Because of tumor heterogeneity, no s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Cheung, Irene Y., Feng, Yi, Gerald, William, Cheung, Nai-Kong V.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2670609/
https://ncbi.nlm.nih.gov/pubmed/18980998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0541
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!